Unicycive Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Unicycive Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
  • Unicycive Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 206 %, a 48.8% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 206 +67.5 +48.8% Sep 30, 2024
Q2 2024 167 +16.2 +10.7% Jun 30, 2024
Q1 2024 134 -51.8 -27.9% Mar 31, 2024
Q4 2023 124 -165 -57% Dec 31, 2023
Q3 2023 138 -300 -68.5% Sep 30, 2023
Q2 2023 151 -664 -81.5% Jun 30, 2023
Q1 2023 186 -338 -64.5% Mar 31, 2023
Q4 2022 289 Dec 31, 2022
Q3 2022 438 Sep 30, 2022
Q2 2022 815 Jun 30, 2022
Q1 2022 524 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.